NANOG and hepatocellular carcinoma: It has been shown that in sorafenib-resistant HCC cells, Nanog expression is promoted by the destabilization and significant downregulation of the transactivation response element RNA binding protein 2, as a result of autophagy-lysosomal protein hydrolysis, promoting the sorafenib resistance of HCC cells (80).